|
|
||||||||
Ann Thorac Surg 2001;71:249-253
© 2001 The Society of Thoracic Surgeons
a Department of Thoracic and Cardiovascular Surgery, Medical School, Hannover, Germany
b Department of Clinical Chemistry II, Medical School, Hannover, Germany
Accepted for publication May 10, 2000.
Address reprint requests to Dr Franke, Klinik für Herz-, Thorax-und Gefäß Chirurgie, Friedrich-Schiller-Universität, Postfach, D-07740 Jena, Germany
e-mail: ulrich.franke{at}med.uni-jena.de
Background. The optimal route for delivery of cardioplegia is still in debate in patients with ischemic heart disease. Cardiac troponin-I is a new marker with the potential for detection of minor differences in myocardial ischemia.
Methods. In a prospective randomized trial 58 patients undergoing elective coronary artery bypass grafting for two- or three-vessel coronary artery disease were divided into groups with antegrade (group A, n = 29) and retrograde (group R, n = 29) application of crystalloid cardioplegia (St. Thomas II). Patients with major risk factors were excluded. In addition to routine electrocardiogram monitoring, cardiac troponin-I and creatine kinase-MB activity were measured in all patients preoperatively at 2, 5, 8, 24, and 48 hours after aortic cross-clamp release, and at hospital discharge.
Results. In both groups, there were no differences regarding operative parameters. A significantly higher cardiac troponin-I concentration was observed in the antegrade group at 24 hours after cross-clamp (8.2 ± 8.5 µg/L vs 3.2 ± 3.1 µg/L; p = 0.02). Patients with subtotal stenosis or occlusion of one or more main coronary arteries showed significantly lower cardiac troponin-I levels after retrograde application.
Conclusions. Lower concentrations of the cardiac troponin-I marker after retrograde application of cardioplegia indicate advantages of myocardial protection in ischemic heart disease.
This article has been cited by other articles:
![]() |
V. Venugopal, A. Ludman, D. M. Yellon, and D. J. Hausenloy 'Conditioning' the heart during surgery Eur J Cardiothorac Surg, June 1, 2009; 35(6): 977 - 987. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Narayan, B. C. Reeves, S. I.A. Rizvi, K. Shokrollahi, H. Ismail, G. D. Angelini, A. Nightingale, and M. Caputo Hemodynamic Evaluation and Midterm Outcome of Aortic Valve Replacement With Size 19 Perimount Prosthetic Valve Ann. Thorac. Surg., December 1, 2008; 86(6): 1799 - 1803. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kulik, M. Al-Saigh, V. Chan, R. G. Masters, P. Bedard, B.-K. Lam, F. D. Rubens, P. J. Hendry, T. G. Mesana, and M. Ruel Enlargement of the Small Aortic Root During Aortic Valve Replacement: Is There a Benefit? Ann. Thorac. Surg., January 1, 2008; 85(1): 94 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Thielmann, P. Massoudy, B. R. Jaeger, M. Neuhauser, G. Marggraf, S. Sack, R. Erbel, and H. Jakob Emergency re-revascularization with percutaneous coronary intervention, reoperation, or conservative treatment in patients with acute perioperative graft failure following coronary artery bypass surgery Eur J Cardiothorac Surg, July 1, 2006; 30(1): 117 - 125. [Full Text] [PDF] |
||||
![]() |
Y. Sakamoto, K. Hashimoto, H. Okuyama, H. Takakura, S. Ishii, S. Taguchi, and H. Kagawa Prevalence and Avoidance of Patient-Prosthesis Mismatch in Aortic Valve Replacement in Small Adults Ann. Thorac. Surg., April 1, 2006; 81(4): 1305 - 1309. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bottio, L. Caprili, D. Casarotto, and G. Gerosa Small aortic annulus: The hydrodynamic performances of 5 commercially available bileaflet mechanical valves J. Thorac. Cardiovasc. Surg., September 1, 2004; 128(3): 457 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bottio, G. Rizzoli, G. Thiene, G. Nesseris, D. Casarotto, and G. Gerosa Hemodynamic and clinical outcomes with the Biocor valve in the aortic position: An 8-year experience J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1616 - 1623. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Selvanayagam, S. E. Petersen, J. M. Francis, M. D. Robson, A. Kardos, S. Neubauer, and D. P. Taggart Effects of Off-Pump Versus On-Pump Coronary Surgery on Reversible and Irreversible Myocardial Injury: A Randomized Trial Using Cardiovascular Magnetic Resonance Imaging and Biochemical Markers Circulation, January 27, 2004; 109(3): 345 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Alex, J. Ansari, R. Guerrero, J. Yogarathnam, A. R. J. Cale, S. C. Griffin, M. E. Cowen, and L. Guvendik Comparison of the immediate post-operative outcome of two different myocardial protection strategies: antegrade-retrograde cold St Thomas blood cardioplegia versus intermittent cross-clamp fibrillation Interact CardioVasc Thorac Surg, December 1, 2003; 2(4): 584 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tasca, F. Brunelli, M. Cirillo, A. Amaducci, Z. Mhagna, G. Troise, and E. Quaini Mass regression in aortic stenosis after valve replacement with small size pericardial bioprosthesis Ann. Thorac. Surg., October 1, 2003; 76(4): 1107 - 1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sharony, E. A. Grossi, P. C. Saunders, C. F. Schwartz, G. H. Ribakove, A. T. Culliford, P. Ursomanno, F. G. Baumann, A. C. Galloway, and S. B. Colvin Minimally Invasive Aortic Valve Surgery in the Elderly: A Case-Control Study Circulation, September 9, 2003; 108(2011): II-43 - II-47. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. F. W. Franke, S. Korsch, T. Wittwer, J. M. Albes, J. Wippermann, M. Kaluza, P. B. Rahmanian, and T. Wahlers Intermittent antegrade warm myocardial protection compared to intermittent cold blood cardioplegia in elective coronary surgery - do we have to change? Eur J Cardiothorac Surg, March 1, 2003; 23(3): 341 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Vitale, S. C. Clark, A. Ramsden, A. Hasan, C. J. Hilton, and M. P. Holden Clinical and hemodynamic evaluation of small perimount aortic valves in patients aged 75 years or older Ann. Thorac. Surg., January 1, 2003; 75(1): 35 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Dieterich Bypass prime and plasma expander can interfere with cardiac troponin I assay Ann. Thorac. Surg., November 1, 2001; 72(5): 1799 - 1799. [Full Text] [PDF] |
||||
![]() |
U. Franke, T. Wahlers, and T. U. Cohnert Bypass prime and plasma expander can interfere with cardiac troponin I assay: Reply Ann. Thorac. Surg., November 1, 2001; 72(5): 1799 - 1800. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |